Navina, an AI-enabled clinical intelligence platform for primary care providers, announced the close of a $55 million Series C funding round, bringing its total raise to $100 million.
Growth Equity at Goldman Sachs Alternatives led the round, with participation from existing investors Vertex Ventures Israel, ALIVE and Grove Ventures.
WHAT IT DOES
Navina offers providers, accountable care organizations, management services organizations and health plans AI-enabled tools for risk adjustment, chart review, quality management and analytics to help track and optimize value-based care performance.
The New York-based company will use the funds to expand across the U.S. and advance its AI technology.
“This investment is a powerful validation of Navina’s vision to improve patient outcomes and healthcare economics by breaking down data barriers with AI,” Ronen Lavi, cofounder and CEO of Navina, said in a statement.
“We’re thrilled to partner with a best-in-class firm like Goldman Sachs, whose market leadership will be instrumental as we enter this pivotal growth phase and expand our market reach. With this additional capital, we will continue to accelerate AI innovation and revolutionize healthcare by making every patient interaction more empathic, personalized, and proactive.”
MARKET SNAPSHOT
In December, Navina announced a strategic partnership with agilon health, a platform aimed at helping physicians better serve their patients at the community level.
Navina’s AI engine was integrated into agilon health’s tech platform to improve efficiency and aid value-based care workflows for agilon’s health network of 2,800 primary care physicians.
In 2023, the company partnered with physician enablement company Privia Health Group, in which Privia would utilize Navina’s AI to enhance value-based care initiatives, workflows and patient care.
In 2022, Navina secured $22 million in Series B funding, doubling its raise at the time to $44 million. A year before, the company raised $15 million in a Series A funding round and, in 2020, closed a $7 million seed funding round.
Credit: Source link
